5 Best Healthcare Stocks Under $20 According to Michael Castor’s Sio Capital

Page 5 of 5

1. Curis, Inc. (NASDAQ:CRIS)

Castor’s Stake Value: $27.1 million

Percentage of Michael Castor’s 13F Portfolio: 6.75%

Number of Hedge Fund Holders: 24

Stock Price as of September 23: $8.00

Curis, Inc. (NASDAQ:CRIS) is a biopharmaceutical company that is involved in the development of therapeutics for the regeneration and restoration of human tissues and organs. Furthermore, the company develops drugs and additional medicine for the treatment of cancer. The company has a market capitalization of $732.77 million and is ranked first on the list of the 10 best healthcare stocks under $20 according to Michael Castor’s Sio Capital.

According to the recent 13F Filings, Michael Castor’s Sio Capital Management holds 3.36 million shares of Curis, Inc. (NASDAQ:CRIS), worth over $27.1 million and representing 6.75% of the fund’s total portfolio value. As of Q2 2021, 24 hedge funds have stakes in Curis, Inc. (NASDAQ: CRIS), worth $314.2 million. This is compared to 29 hedge funds in the preceding quarter with a total stake value of approximately $493 million.

On August 3, Curis, Inc. (NASDAQ:CRIS) issued its quarterly earnings report for the second quarter of 2021, with reported earnings per share at -$0.12, falling short of market estimates of -$0.11 by $0.01. In addition, the company reported revenues of $2.29 million, missing estimates by $0.26 million.

On May 13, B. Riley analyst Justin Walsh raised the firm’s price target on Curis, Inc. (NASDAQ:CRIS) to $22 from $19 and reiterated a Buy rating on the shares.

Out of the hedge funds being tracked by Insider Monkey’s database, Boston-based investment firm RA Capital Management is a leading shareholder in Curis, Inc. (NASDAQ:CRIS) with over 7.14 million shares worth more than $57.6 million.

You can also take a look at 20 Best Places to Invest in Rental Property in 2021 and 10 Stocks to Buy and Hold According to Bill Gates.

Page 5 of 5